Safeguarding Global Health
Sentinel-Enabled Biosecurity Preparedness for a Safer Future
Avicena’s Biosecurity Preparedness solution enables nations and organisations to build resilient and scalable systems for rapid identification and containment of potential outbreaks.
A Continuing Need to Safeguard Our Lives & Economies
As the world becomes more interconnected, the risk of pandemics causing widespread devastation has never been higher.
The COVID-19 crisis revealed the inadequacy of global biosecurity infrastructure and the urgent need for more agile systems to meet new threats.
Recognising the importance of One Health for human and animal biosecurity preparedness, governments are now investing in creating advanced solutions for robust defences against future threats.
Avicena Sentinel Enables Biosecurity Preparedness
Avicena Sentinel is the world’s most scalable rapid molecular diagnostics platform, offering a daily surge capability of up to 100,000 tests.
The fully automated solution also offers flexible and on-demand sample loading, ensuring cost-effective testing for various volumes.
Sentinel’s comfortable saliva or nasal sample self-collection takes less than 20 seconds, and can be adapted for alternative sample matrices.
As a platform based on LAMP, a sensitive technology similar to PCR, Sentinel can readily adapt to existing tests for a wide variety of human and animal pathogens
Protecting Human Lives & Livelihoods
Protecting Livestock & Food Security
Avicena Sentinel enables livestock and food industries to rapidly detect and monitor infectious diseases at any scale to safeguard animal health and food supply chains.
Flexible Biosecurity Platform
Sentinel ULTRA V3
Surge capacity up to 100,000 daily
Up to 10x faster than PCR
Continuous Flow Processing
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting
Sentinel has achieved a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.
CE-Mark for COVID test chemistry developed by Hayat Genetics, acquired by Avicena Systems.